Rhythm Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.
RYTM Key Statistics
Stock Snapshot
The current Rhythm Pharmaceuticals(RYTM) stock price is $111.10, with a market capitalization of 7.41B. The stock trades at a price-to-earnings (P/E) ratio of -36.18.
During the trading session on 2025-12-26, Rhythm Pharmaceuticals(RYTM) shares reached a daily high of $112.41 and a low of $110.57. At a current price of $111.10, the stock is +0.5% higher than the low and still -1.2% under the high.
Trading volume for Rhythm Pharmaceuticals(RYTM) stock has reached 196.38K, versus its average volume of 1.27M.
The stock's 52-week range extends from a low of $45.91 to a high of $122.20.
The stock's 52-week range extends from a low of $45.91 to a high of $122.20.
RYTM News
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...